ABT · News · 20261102N

SonicForce Product Development

ABBOTT LABORATORIES · 2026-11-02 · Importance 26 · Surprise 24

Abbott’s investigational SonicForce Coronary Intravascular Lithotripsy System met safety and effectiveness goals in the TECTONIC study, with a 97% procedural success rate. The results add clinical evidence for Abbott’s coronary intravascular lithotripsy technology in patients with severely calcified coronary arteries. The findings were highlighted alongside other cardiovascular-device trial results at the Transcatheter Cardiovascular Therapeutics conference.

Key facts